Get startedLog in
    Picture of Shanghai Junshi Biosciences logo

    1877 — Shanghai Junshi Biosciences News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapSucker Stock
    All News

    Brief: Shanghai Junshi Biosciences Announces Approval For Marketing Of Toripalimab In Hong Kong

    Picture of Shanghai Junshi Biosciences logoShanghai Junshi Biosciences
    15/10/2024 15:56
    Oct 15 (Reuters) - Shanghai Junshi Biosciences Co Ltd
 688180.SS :
    * APPROVAL FOR MARKETING OF TORIPALIMAB IN HONG KONG SAR,
CHINA
    * UNIT GRANTED CERTIFICATE OF DRUG/PRODUCT REGISTRATION
ISSUED BY
PHARMACY AND POISONS BOARD OF HONG KONG

Further company coverage:  688180.SS 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Shanghai Junshi Biosciences

    See all news